Developing a Framework of Cost Elements of Socioeconomic Burden of Rare Disease: A Scoping Review.
Currie GR, Gerber B, Lorenzetti D, MacDonald K, Benseler SM, Bernier FP, Boycott KM, Carias KV, Hamelin B, Hayeems RZ, LeBlanc C, Twilt M, van Rooijen G, Wong-Rieger D, Yeung RSM, Marshall DA.
Currie GR, et al. Among authors: van rooijen g.
Pharmacoeconomics. 2023 Jul;41(7):803-818. doi: 10.1007/s40273-023-01262-x. Epub 2023 Apr 7.
Pharmacoeconomics. 2023.
PMID: 37029233
Review.